3652 results for «231»
3652 results
STEMI and unusual thrombus
16 May 2023 – From EuroPCR 2023
If you'd like to deepen your understanding of complications in ST-segment elevation myocardial infarction, join the speakers as they present a series of cases focusing on atypical thrombus formation.
Heterotopic valve replacement for patients with right heart failure and tricuspid regurgitation - All you need to know!
17 May 2023 – From EuroPCR 2023
Discover the comprehensive guide to heterotopic valve replacement for patients experiencing right heart failure and tricuspid regurgitation. Join this session to gain insights into patient selection criteria, delve into the concept behind this innovative procedure, and grasp the fundamental aspects of its execution.
Complex PCI in high bleeding risk patients: adjust your strategy!
17 May 2023 – From EuroPCR 2023
With the guidance of a live case from the Clinique Pasteur in Toulouse - multivessel PCI in a patient at high bleeding risk- and the latest results from the MASTER DAPT randomized trial that enrolled patients treated exclusively with the Ultimater stent, the presenters invite us...
When dissection occurs during primary PCI
16 May 2023 – From EuroPCR 2023
Discover the complexities surrounding dissection during primary percutaneous coronary intervention (PCI). Immerse yourself in the challenges, implications and strategies employed to manage this critical scenario skillfully.
More pulses to take you further across all calcium morphologies
17 May 2023 – From EuroPCR 2023
Discover the latest insights on intravascular lithotripsy (IVL) for treating calcified lesions: explore its mechanism of action, technological advancements, and practical tips for challenging cases, including diffuse lesions, left main bifurcations, and eccentric/calcified nodules. Enhance your expertise in IVL with this concise and informative session!
The future of physiology- and morphology-guided PCI is optical!
17 May 2023 – From EuroPCR 2023
Join this session to explore the advantages of a fully optical approach in optimizing percutaneous coronary intervention (PCI) with the OptoWire III physiology wire and Nipro HF-OCT catheter. Through a practical case, you'll discover the significance of coronary physiology and intravascular imaging in bifurcation PCI and...
Calcified lesions: how to treat
16 May 2023 – From EuroPCR 2023
Learn more about the treatment of calcified lesions in this session, where speakers dissect a collection of cases focusing on tough situations.
Making treatment and management of complex PCIs easier with Cre8 EVO
17 May 2023 – From EuroPCR 2023
Maximize patient clinical outcomes in complex percutaneous coronary interventions (PCIs) by joining this session. Discover how accurate patient evaluation, advanced imaging/functional modalities, optimized procedures, and the Cre8 EVO device contribute to improved safety and efficacy, and review the challenges associated with DES implantation in complex PCIs.
PCR Tokyo Valves 2026: Your travel guide featuring upcoming exclusive booking services and special deals.
Percutaneous or surgical management of post-infarction ventricular septal defects: The United Kingdom National Registry
17 Sep 2022
Elad Asher provides his take on the UK National Registry which was presented at the TCT congress 2022 by Joel Peter Giblett on behalf of the UK PIVSD investigators.
Author
EuroPCR 2026 – Long-term mortality following revascularisation for left main disease
20 May 2026
Paris, France, 19−22 May 2026. The EuroPCR Course Directors have selected 3 major late-breaking trials that will be presented for the first time during EuroPCR 2026 and are set to impact practice worldwide. Among them is a meta-analysis of long-term data from 4 randomised trials investigating...
OPTIMUM: Outcomes of Percutaneous RevascularizaTIon for Management of SUrgically Ineligible Patients with Multivessel or Left Main Coronary Artery Disease
04 Nov 2021
Mirvat Alasnag reviews the OPTIMUM trial, presented by David E. Kandzari, which reports outcomes in a subset of patients who are increasingly seen in modern day catheterization laboratories. It is noteworthy that 1 in 5 patients with left main or multivessel disease are considered surgically ineligible.
Author
